World Renowned Gastroenterologists Perform First Ever Live MUSE Procedure at Winthrop University Hospital

OMER, Israel, June 10, 2015 - Medigus Ltd. (Nasdaq:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced that the first ever live Medigus Ultrasonic Surgical Endostapler (MUSE) procedure in the Unites States was performed by leading gastroenterologists, Drs. Glen Lehman and William Kessler, at Winthrop-University Hospital in Mineola, NY in late March. Dr. Stavros Stavropoulos, Chief of Endoscopy and Director, Program in Advanced GI Endoscopy (PAGE), Winthrop-University Hospital, who performed the first MUSE procedure at Winthrop this past January, moderated the procedure for an audience of medical colleagues and students at the 7th Annual Long Island Live Endoscopy Course. The MUSE system is used for an incisionless procedure for the treatment of gastroesophageal reflux disease (GERD) and is leading the transition to more patient-friendly procedures for the long-term treatment of this prevalent disorder.

Dr. Lehman, Professor of Medicine and Radiology at Indiana University Medical Center, and Dr. Kessler, Associate Professor of Medicine at Indiana University Medical Center, have considerable experience treating many digestive disorders through flexible endoscopic surgery.

"It was an honor to be included in Winthrop-University Hospital's educational curriculum to highlight this innovative new procedure for the treatment of GERD, a condition that affects millions of Americans every year," said Dr. Kessler. "Traditional treatment options are either symptom management or invasive surgical procedures to address a dysfunctional lower esophageal sphincter. MUSE, however, addresses the root cause of the disorder, without incisions, to deliver a long-term solution for those suffering from persistent symptoms."

The MUSE system is an intuitive device that integrates recent breakthroughs in visualization, ultrasound and surgical stapling capabilities, into a single platform, making it easy for a single physician to perform fundoplication (stapling of the upper part of the stomach, or fundus, to the lower esophageal sphincter) for the treatment of GERD. MUSE has the potential to improve GERD-related quality of life for many patients by addressing the root cause of the disorder, not just offer symptom relief, which is often in contrast to many drug therapies.

"As a recognized leader in GI care, Winthrop-University Hospital seeks to offer our patients advanced treatment technologies. I performed the first MUSE procedure at Winthrop earlier this year, and am now pleased to be part of the first live procedure to help educate the GI community on the benefits of MUSE over existing therapies for the treatment of GERD," said Dr. Stravropoulos. "Drs. Lehman and Kessler demonstrated the ease with which this procedure can be performed and we expect more and more GI specialists will adopt this new technique."